| Date Filed | Type | Description |
| 08/14/2023 |
4
| WEISS MICHAEL S (CEO and President) has filed a Form 4 on TG THERAPEUTICS, INC.|
Txns:
| Bought 100,000 shares
@ $10.13, valued at
$1M
|
|
| 07/07/2023 |
4
| WEISS MICHAEL S (Director) has filed a Form 4 on MUSTANG BIO, INC.|
Txns:
| Granted 7,246 shares
@ $0 |
|
| 06/15/2023 |
4
| WEISS MICHAEL S (Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 17,483 shares
@ $0 |
|
| 04/06/2023 |
3/A
| WEISS MICHAEL S (Director) has filed a Form 3/A on MUSTANG BIO, INC. |
| 04/03/2023 |
4
| WEISS MICHAEL S (Director) has filed a Form 4 on MUSTANG BIO, INC.|
Txns:
| Granted 71,664 shares
@ $0 |
|
| 03/14/2023 |
4
| WEISS MICHAEL S (CEO and President) has filed a Form 4 on TG THERAPEUTICS, INC.|
Txns:
| Granted 985,000 shares
@ $0 |
|
| 01/04/2023 |
4
| WEISS MICHAEL S (See Remarks) has filed a Form 4 on Fortress Biotech, Inc.|
Txns:
| Granted 1,219,294 shares
@ $0 |
|
| 07/22/2022 |
4
| WEISS MICHAEL S (CEO and President) has filed a Form 4 on TG THERAPEUTICS, INC.|
Txns:
| Granted 1,900,000 options to buy
@ $7, valued at
$13.3M
|
|
| 06/24/2022 |
4
| WEISS MICHAEL S (Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 47,619 shares
@ $0 |
|
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2022 |
4
| WEISS MICHAEL S (CEO and President) has filed a Form 4 on TG THERAPEUTICS, INC.|
Txns:
| Gifted 3,000 shares
@ $0
Gifted 700,000 shares
@ $0
Gifted 9,000 shares
@ $0
Granted 56,394 shares
@ $0
Sold 37,549 shares
@ $19.2, valued at
$720.9k
Sold 30,671 shares
@ $18.31, valued at
$561.6k
|
|
| 07/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2021 |
4
| WEISS MICHAEL S (CEO and President) has filed a Form 4 on TG THERAPEUTICS, INC.|
Txns:
| Granted 1,080,770 shares
@ $0 |
|
| 06/11/2021 |
4
| WEISS MICHAEL S (Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 16,502 shares
@ $0 |
|
| 04/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/31/2020 |
5
| WEISS MICHAEL S (CEO and President) has filed a Form 5 on TG THERAPEUTICS, INC. |
| 08/19/2020 |
4
| WEISS MICHAEL S (Director) has filed a Form 4 on MUSTANG BIO, INC.|
Txns:
| Granted 16,611 shares
@ $0 |
|
| 06/24/2020 |
4
| WEISS MICHAEL S (CEO and President) has filed a Form 4 on TG THERAPEUTICS, INC.|
Txns:
| Granted 1,556,029 shares
@ $0 |
|
| 06/09/2020 |
4
| WEISS MICHAEL S (Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 24,390 shares
@ $0 |
|
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2020 |
4
| WEISS MICHAEL S (Director) has filed a Form 4 on MUSTANG BIO, INC.|
Txns:
| Granted 10,000 shares
@ $0
Granted 13,812 shares
@ $0 |
|
| 06/27/2019 |
4
| WEISS MICHAEL S (CEO and President) has filed a Form 4 on TG THERAPEUTICS, INC.|
Txns:
| Bought 50,000 shares
@ $7.035, valued at
$351.8k
|
|
| 06/14/2019 |
4
| WEISS MICHAEL S (Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 11,442 shares
@ $0 |
|
| 06/14/2019 |
4
| WEISS MICHAEL S (CEO and President) has filed a Form 4 on TG THERAPEUTICS, INC.|
Txns:
| Granted 1,179,380 shares
@ $0 |
|
| 04/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2018 |
4
| WEISS MICHAEL S (Director) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Gifted 14,663 shares
@ $0 |
|
| 06/28/2018 |
4
| WEISS MICHAEL S (CEO and President) has filed a Form 4 on TG THERAPEUTICS, INC.|
Txns:
| Granted 1,018,011 shares
@ $0 |
|
| 06/15/2018 |
4
| WEISS MICHAEL S (Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 16,448 shares
@ $0 |
|
| 08/18/2017 |
3
| WEISS MICHAEL S (Director) has filed a Form 3 on AVENUE THERAPEUTICS, INC. |
| 07/20/2017 |
3/A
| WEISS MICHAEL S (Exec. Chairman of the Board) has filed a Form 3/A on MUSTANG BIO, INC. |
| 06/30/2017 |
3
| WEISS MICHAEL S (Exec. Chairman of the Board) has filed a Form 3 on MUSTANG BIO, INC. |
| 06/19/2017 |
4
| WEISS MICHAEL S (CEO and President) has filed a Form 4 on TG THERAPEUTICS, INC. |
| 06/15/2017 |
4
| WEISS MICHAEL S (Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 01/27/2017 |
SC 13D/A
| WEISS MICHAEL S reports a 14.5% stake in FORTRESS BIOTECH, INC. |
|